A concentrated pharmaceutical position. The obesity and diabetes franchise drives the great majority of growth, so the holding rises and falls on prescription volumes, manufacturing capacity and trial readouts rather than on the broader market. Concentration is the risk: competitor trial data or a reimbursement decision can reprice the stock in a single session.
Four ways to hold this position. The tier you choose sets the minimum, the holding period, and how actively the allocation is managed.
A single-position entry. You hold a fractional allocation of the instrument and take the full price move, up or down, with no leverage applied.
Deposit at StarterA managed allocation. Your capital is averaged into the position across several entries to smooth out the entry price, and dividends where paid are reinvested.
Deposit at GrowthA hedged allocation. The core position is paired with a downside hedge so a sharp drawdown in the underlying is partially offset, at the cost of capping some upside.
Deposit at PremiumA mandated allocation with a named portfolio manager, custom rebalancing bands and monthly written reporting on the position.
Deposit at Institutional